๐๏ธ Verified NIH Record โข Updated 2025-12-02
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation (NCT06056271)
๐ข Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: Volta Medical
๐ฉบ Plain-English Summary (8th-Grade Level)
Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.
Who can join: Review the eligibility criteria below.
Location: Endeavor Health โ Evanston, Illinois
Age range: 21 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (4 Sites)
- Endeavor Health โ Evanston, Illinois
- Kansas City Cardiac Arrhythmia Research LLC โ Overland Park, Kansas
- Northwell Health โ New York, New York
- Ohio State University โ Columbus, Ohio
๐ Contact the Study Coordinator
Phone: (612) 227-1483
Email: daniel.guerrero@volta-medical.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atrial Fibrillation
- CHAMPION-AF Clinical Trial โ Birmingham, Alabama
- Reversal of Atrial Substrate to Prevent Atrial โ Calgary, Alberta
- Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients โ Rochester, New York
- REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry โ Chandler, Arizona
- Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) โ Cleveland, Ohio
- Liraglutide Effect in Atrial Fibrillation โ Miami, Florida
Explore by condition: All Atrial Fibrillation clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.